One-Year Survival Following Early Revascularization for Cardiogenic Shock
Top Cited Papers
Open Access
- 10 January 2001
- journal article
- clinical trial
- Published by American Medical Association (AMA) in JAMA
- Vol. 285 (2) , 190-192
- https://doi.org/10.1001/jama.285.2.190
Abstract
Cardiogenic shock (CS) is the leading cause of death for patients hospitalized with acute myocardial infarction (AMI),1,2 and mortality remains high during the following year.3,4 The SHOCK (Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock) Trial demonstrated a nonsignificant reduction in 30-day mortality (56% vs 47%) when early revascularization (ERV) was compared with a strategy of initial medical stabilization (IMS), with a larger difference between the groups at 6 months.5 In this article, we report the 1-year survival, a prespecified secondary end point of the SHOCK Trial.Keywords
This publication has 1 reference indexed in Scilit: